Wesana Health Holdings Stock Performance
| WSNAF Stock | USD 0 0 28.33% |
Wesana Health holds a performance score of 9 on a scale of zero to a hundred. The firm maintains a market beta of 2.03, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Wesana Health will likely underperform. Use Wesana Health Holdings value at risk, kurtosis, period momentum indicator, as well as the relationship between the semi variance and day median price , to analyze future returns on Wesana Health Holdings.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Wesana Health Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Wesana Health reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.3 M | |
| Free Cash Flow | -12 M |
Wesana |
Wesana Health Relative Risk vs. Return Landscape
If you would invest 0.79 in Wesana Health Holdings on September 3, 2024 and sell it today you would lose (0.36) from holding Wesana Health Holdings or give up 45.57% of portfolio value over 90 days. Wesana Health Holdings is currently producing 4.1017% returns and takes up 34.2595% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Wesana, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Wesana Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Wesana Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Wesana Health Holdings, and traders can use it to determine the average amount a Wesana Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1197
| Best Portfolio | Best Equity | WSNAF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 34.26 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.1 actual daily | 81 81% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Wesana Health is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Wesana Health by adding it to a well-diversified portfolio.
Wesana Health Fundamentals Growth
Wesana Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Wesana Health, and Wesana Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Wesana Pink Sheet performance.
| Return On Equity | -1.72 | |||
| Return On Asset | -0.42 | |||
| Operating Margin | (49.56) % | |||
| Current Valuation | (851.39 K) | |||
| Shares Outstanding | 20.49 M | |||
| Price To Book | 0.21 X | |||
| Price To Sales | 2.53 X | |||
| Revenue | 267.2 K | |||
| EBITDA | (34.26 M) | |||
| Cash And Equivalents | 1.77 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 1.14 M | |||
| Debt To Equity | 0.28 % | |||
| Book Value Per Share | 0.05 X | |||
| Cash Flow From Operations | (11.99 M) | |||
| Earnings Per Share | (1.27) X | |||
| Total Asset | 9.74 M | |||
About Wesana Health Performance
By analyzing Wesana Health's fundamental ratios, stakeholders can gain valuable insights into Wesana Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Wesana Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Wesana Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. Wesana Health operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Wesana Health Holdings performance evaluation
Checking the ongoing alerts about Wesana Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Wesana Health Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Wesana Health is way too risky over 90 days horizon | |
| Wesana Health has some characteristics of a very speculative penny stock | |
| Wesana Health appears to be risky and price may revert if volatility continues | |
| Wesana Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 267.2 K. Net Loss for the year was (34.34 M) with profit before overhead, payroll, taxes, and interest of 10.12 K. | |
| Wesana Health Holdings has accumulated about 1.77 M in cash with (11.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Wesana Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Wesana Health's stock is overvalued or undervalued compared to its peers.
- Examining Wesana Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Wesana Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Wesana Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Wesana Health's pink sheet. These opinions can provide insight into Wesana Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Wesana Pink Sheet analysis
When running Wesana Health's price analysis, check to measure Wesana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wesana Health is operating at the current time. Most of Wesana Health's value examination focuses on studying past and present price action to predict the probability of Wesana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wesana Health's price. Additionally, you may evaluate how the addition of Wesana Health to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |